Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap

Key Findings

• ●TKI roadmap from imatinib to selective KIT D816V inhibitors
• ●Only rare KIT D816V-negative cases initially responsive to early TKIs

Referenced in (1 disease)